Vagus nerve ear clips are transcutaneous auricular VNS (taVNS) devices that attach to the ear with a clip-style electrode, delivering mild electrical stimulation to the auricular branch of the vagus nerve. They are the most common form factor for consumer and clinical taVNS devices, and the product category has expanded rapidly since 2020. This article covers what ear clip devices are, how they differ from each other, and what to look for when choosing one.
How Ear Clip Devices Work
All ear clip VNS devices operate on the same principle: they deliver low-intensity electrical current (typically 0.1-5 mA) through electrodes that contact the skin of the ear at points innervated by the auricular branch of the vagus nerve (ABVN). The electrical current activates the ABVN’s sensory fibres, which project to brainstem nuclei (primarily the nucleus tractus solitarius via the spinal trigeminal nucleus), producing downstream effects on autonomic tone, inflammation, mood, and other vagally modulated functions.
The “clip” form factor means the device attaches to the ear using spring tension, pinch pressure, or a custom-fitted ear insert. The electrodes are positioned to contact the ear’s vagally innervated regions — typically the tragus (the cartilage flap in front of the ear canal), the cymba conchae (the upper bowl of the ear), or both. The user adjusts the stimulation intensity to produce a comfortable tingling sensation without pain — this is the standard “perception threshold” approach used in clinical taVNS research.
Available Devices
NEMOS (Cerbomed). A clinical-grade taVNS device developed in Germany, primarily used in European clinical trials for epilepsy and depression. It uses a custom intra-concha electrode that fits into the cymba conchae. NEMOS has the most extensive published clinical trial data of any taVNS device and has CE marking in Europe for epilepsy. It is available by prescription in some European countries. Typical parameters: 25 Hz, 250 microsecond pulse width, 30 seconds on/30 seconds off duty cycle, 1-4 hours daily.
Parasym/Nurosym. Originally marketed as Parasym, now rebranded as Nurosym. A consumer taVNS device using a tragus clip electrode. Nurosym has been used in several published studies, including research on HRV improvement, inflammation reduction, and cardiac autonomic function. The device uses 25 Hz stimulation with adjustable intensity and a companion app for session management. Priced at approximately $500-600 USD. Nurosym has positioned itself in the evidence-based segment of the consumer market, with more published research backing than most competitors.
Pulsetto. A consumer taVNS device using a neck-worn design with bilateral electrodes — this is technically a cervical VNS form factor rather than an ear clip. Included here because it is frequently compared to ear clip devices. Pulsetto applies stimulation to the cervical vagus nerve area through the skin of the neck. Priced at approximately $280-350 USD. Limited published clinical evidence specific to the device, though the cervical stimulation approach has a general evidence base through gammaCore research.
Hoolest VeRelief. A handheld device that applies cervical stimulation through the neck. Again not an ear clip, but commonly compared. Priced at approximately $250-400 USD. Limited published evidence specific to the device.
Generic taVNS ear clips. Various unbranded or generic taVNS ear clip devices are available through online retailers for $30-150 USD. These typically consist of a TENS-style pulse generator connected to an ear clip electrode. They deliver electrical stimulation to the ear, but the specific parameters (waveform shape, frequency stability, current control accuracy) may not match the specifications of clinically tested devices. The electrode placement may also be less precise — a clip that sits on the ear lobe rather than the tragus or cymba conchae will not stimulate the ABVN effectively.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,685 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
- Clinician-applied tVNS
- Implanted VNS and neuromodulation
- Polyvagal-informed therapy
- Somatic therapy
- HRV biofeedback
- Craniosacral therapy
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
What to Look For
Electrode placement. The most important factor. The device must place its electrodes on the cymba conchae and/or tragus — the areas with confirmed ABVN innervation. Ear lobe stimulation does not activate the vagus nerve (the ear lobe has no vagal innervation). If a device clips to the ear lobe, it is not performing taVNS regardless of what it claims.
Stimulation parameters. Look for devices that use parameters consistent with the clinical research: frequency of 25 Hz (the most commonly validated frequency), pulse width of 200-500 microseconds, adjustable intensity (0.1-5 mA range, adjusted to perception threshold), and a duty cycle that allows both stimulation and rest periods (30 seconds on/30 seconds off is common in research, though some protocols use continuous stimulation for shorter sessions).
Current control vs voltage control. Clinical-grade devices use constant current stimulation — the device adjusts its voltage to deliver a consistent current regardless of skin impedance changes. Cheaper devices may use constant voltage, which means the actual current delivered to the nerve varies with skin moisture, electrode contact pressure, and other factors. Constant current is preferred for consistent and safe stimulation.
Published evidence. Has the specific device been used in published clinical studies? This is the strongest evidence that the device actually delivers what it claims. General taVNS evidence supports the concept, but device-specific validation confirms that the particular hardware implements the concept correctly.
Safety features. Look for maximum current limiting (prevents accidental overstimulation), gradual ramp-up at session start (avoids startling the user), and automatic shutoff after the programmed session duration.
Limitations of Ear Clip Devices
Ear clip taVNS devices have real limitations that should be understood. The ABVN is a small sensory branch — stimulating it activates the vagal brainstem pathway, but with less intensity and specificity than implanted VNS, which directly stimulates the main vagal trunk. For serious medical conditions (refractory epilepsy, treatment-resistant depression), ear clip taVNS is a supplement or alternative for patients who cannot undergo surgery — not a replacement for implanted VNS, which has stronger evidence and greater efficacy. Individual response varies — some people experience clear benefits from taVNS, while others notice little effect. Compliance matters — the clinical evidence uses daily sessions of 30-60 minutes, and skipping sessions reduces the benefit. The consumer market includes devices with unsupported claims — not every ear clip that claims to stimulate the vagus nerve actually does so effectively.
For a broader comparison including implanted and cervical devices, see our comprehensive review of vagus nerve stimulation devices.
Choosing the right VNS device means understanding both the technology and the evidence. My Vagus Nerve & Me covers the full range of stimulation options. Get My Vagus Nerve & Me eBook and make an informed choice.
